Gilead and Merck initiate phase-II study on Lenacapavir and Islatravir oral combo for HIV-1… EP News Bureau Oct 27, 2021 This clinical study is the first from Merck and Gilead’s collaboration to develop potential long-acting HIV treatment options
Clinical Data Standards in the era of AI, ML and digital transformation EP News Bureau Feb 8, 2021 Shrishaila Patil, VP, Statistical Programming, Navitas Data Sciences, a part of Navitas Life Sciences (a TAKE Solutions…
UK strikes deal with GSK and Sanofi for 60 mn doses of COVID-19 vaccine Press Trust of India Jul 30, 2020 The British government said the latest deal helps grow the country’s portfolio of vaccine candidates and adds to previous…
